NVX vs. ULBI, STEM, GWH, ELVA, CBAT, FLUX, SES, WBX, ONTF, and DOMO
Should you be buying NOVONIX stock or one of its competitors? The main competitors of NOVONIX include Ultralife (ULBI), Stem (STEM), ESS Tech (GWH), Electrovaya (ELVA), CBAK Energy Technology (CBAT), Flux Power (FLUX), SES AI (SES), Wallbox (WBX), ON24 (ONTF), and Domo (DOMO). These companies are all part of the "computer and technology" sector.
NOVONIX (NASDAQ:NVX) and Ultralife (NASDAQ:ULBI) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, community ranking, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.
In the previous week, NOVONIX had 1 more articles in the media than Ultralife. MarketBeat recorded 5 mentions for NOVONIX and 4 mentions for Ultralife. Ultralife's average media sentiment score of 0.85 beat NOVONIX's score of 0.74 indicating that Ultralife is being referred to more favorably in the news media.
Ultralife has a consensus target price of $13.00, suggesting a potential upside of 11.30%. Given Ultralife's higher possible upside, analysts clearly believe Ultralife is more favorable than NOVONIX.
Ultralife has higher revenue and earnings than NOVONIX.
Ultralife received 261 more outperform votes than NOVONIX when rated by MarketBeat users.
NOVONIX has a beta of 3.16, suggesting that its share price is 216% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.
0.1% of NOVONIX shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 23.7% of NOVONIX shares are owned by insiders. Comparatively, 42.7% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Ultralife has a net margin of 6.19% compared to NOVONIX's net margin of 0.00%. Ultralife's return on equity of 10.31% beat NOVONIX's return on equity.
Summary
Ultralife beats NOVONIX on 11 of the 14 factors compared between the two stocks.
Get NOVONIX News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
